drugset / Trial / NCT06712420

Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)

NCT06712420 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

to study role of chemotherapy treatment for gall bladder cancer before surgery as compared to surgery directly

Timeline

Start
2025-01-01
Primary completion
2028-04
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — —
Subject Cisplatin Other / unclassified 75 mg/m2 Intravenous
Subject Gemcitabine Small molecule 1000 mg/m2 Intravenous

Indications